- Home
- GPCR vs XNDU Comparison
GPCR vs XNDU Comparison
Compare GPCR & XNDU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | GPCR | XNDU |
|---|---|---|
| Founded | 2016 | 2016 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | | |
| Sector | | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.8B | 3.5B |
| IPO Year | 2023 | 2025 |
Fundamental Metrics
Financial Performance| Metric | GPCR | XNDU |
|---|---|---|
| Price | $38.79 | $9.06 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 12 | 2 |
| Target Price | ★ $103.17 | $44.00 |
| AVG Volume (30 Days) | 755.9K | ★ 1.3M |
| Earning Date | 05-08-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $20.04 | $6.97 |
| 52 Week High | $94.90 | $42.44 |
Technical Indicators
Market Signals| Indicator | GPCR | XNDU |
|---|---|---|
| Relative Strength Index (RSI) | 27.86 | 36.39 |
| Support Level | $36.11 | N/A |
| Resistance Level | $41.50 | $11.57 |
| Average True Range (ATR) | 2.45 | 0.55 |
| MACD | -1.11 | -0.12 |
| Stochastic Oscillator | 2.07 | 3.27 |
Price Performance
Historical ComparisonAbout GPCR Structure Therapeutics Inc.
Structure Therapeutics Inc is a clinical-stage biopharmaceutical company developing novel oral small-molecule therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its differentiated technology platform leverages both structure-based drug discovery and expertise in computational chemistry to discover and develop small molecule therapeutics against G-protein coupled receptors (GPCRs). The group operates and manages its business as one reportable and operating segment, which is the business of research and development of medicines that target chronic diseases with unmet medical needs.
About XNDU Xanadu Quantum Technologies Limited Class B Subordinate Voting Shares
Xanadu Quantum Technologies Ltd specializes in designing photonic devices and the platforms around them, including the experimentation and development of quantum computers available on the cloud with supporting software, along with quantum simulators and other related products and offerings. Its products include: Aurora, PennyLane, Catalyst, Lightning, Catalyst and PennyLane Codebook. The company operates in industries such as automotive, aerospace, energy, materials, and semiconductor sectors.